Nitrosative stress predicts the presence and severity of nonalcoholic fatty liver at different stages of the development of insulin resistance and metabolic syndrome: possible role of vitamin A intake
- PMID: 17823431
- DOI: 10.1093/ajcn/86.3.661
Nitrosative stress predicts the presence and severity of nonalcoholic fatty liver at different stages of the development of insulin resistance and metabolic syndrome: possible role of vitamin A intake
Abstract
Background: Although nonalcoholic fatty liver disease (NAFLD) is associated with the metabolic syndrome, the mechanisms responsible for the development of NAFLD at different stages of the development of insulin resistance are unknown. Diet, adipokines, and nitrosative stress have been linked to both NAFLD and insulin resistance.
Objective: We aimed to identify the factors that are specifically associated with NAFLD at different stages in the development of insulin resistance and the metabolic syndrome.
Design: Circulating concentrations of adipokines (ie, tumor necrosis factor-alpha, adiponectin, resistin, leptin, and interleukin-6), markers of nitrosative stress (nitrotyrosine), dietary habits, and MTP -493G/T polymorphism were cross-sectionally related to the presence and severity of insulin resistance (homeostasis model assessment index for insulin resistance: >or=2), the metabolic syndrome, and fatty liver in 64 nonobese nondiabetic patients with NAFLD (33 insulin-sensitive and 31 insulin-resistant subjects) and 74 control subjects without liver disease who were matched for sex, BMI, homeostasis model assessment index for insulin resistance status, and the various features of the metabolic syndrome.
Results: Persons with NAFLD had greater systemic nitrosative stress and a lower intake of vitamins A and E than did control subjects, but the 2 groups did not differ significantly in any other features. Nitrotyrosine and adiponectin concentrations and vitamin A intakes independently predicted alanine aminotransferase concentrations in NAFLD patients and liver histology in a subgroup of 29 subjects with biopsy-proven nonalcoholic steatohepatitis.
Conclusions: Oxidative stress is operating in NAFLD and nonalcoholic steatohepatitis, even in the absence of insulin resistance, the metabolic syndrome, and hypoadiponectinemia, which aggravate liver histology at more severe stages of metabolic disease. The possible pathogenetic role of reduced vitamin A intake in NAFLD warrants further investigation.
Similar articles
-
Should nonalcoholic fatty liver disease be included in the definition of metabolic syndrome? A cross-sectional comparison with Adult Treatment Panel III criteria in nonobese nondiabetic subjects.Diabetes Care. 2008 Mar;31(3):562-8. doi: 10.2337/dc07-1526. Epub 2007 Dec 4. Diabetes Care. 2008. PMID: 18056890
-
Irisin in patients with nonalcoholic fatty liver disease.Metabolism. 2014 Feb;63(2):207-17. doi: 10.1016/j.metabol.2013.09.013. Epub 2013 Oct 18. Metabolism. 2014. PMID: 24140091
-
Triglyceride levels and not adipokine concentrations are closely related to severity of nonalcoholic fatty liver disease in an obesity surgery cohort.Obesity (Silver Spring). 2009 Sep;17(9):1696-701. doi: 10.1038/oby.2009.89. Epub 2009 Apr 9. Obesity (Silver Spring). 2009. PMID: 19360015 Free PMC article.
-
Fructose as a key player in the development of fatty liver disease.World J Gastroenterol. 2013 Feb 28;19(8):1166-72. doi: 10.3748/wjg.v19.i8.1166. World J Gastroenterol. 2013. PMID: 23482247 Free PMC article. Review.
-
[The role of adipokines and insulin resistance in the pathogenesis of nonalcoholic fatty liver disease].Postepy Hig Med Dosw (Online). 2010 May 7;64:212-9. Postepy Hig Med Dosw (Online). 2010. PMID: 20498498 Review. Polish.
Cited by
-
Nonalcoholic Fatty Liver Disease (NAFLD). Mitochondria as Players and Targets of Therapies?Int J Mol Sci. 2021 May 20;22(10):5375. doi: 10.3390/ijms22105375. Int J Mol Sci. 2021. PMID: 34065331 Free PMC article. Review.
-
The association between SNPs rs1800591 and rs3816873 of the MTTP gene and nonalcoholic fatty liver disease: A meta-analysis.Saudi J Gastroenterol. 2020 Jul 23;26(4):171-8. doi: 10.4103/sjg.SJG_201_20. Online ahead of print. Saudi J Gastroenterol. 2020. PMID: 32719241 Free PMC article.
-
iNOS contributes to heart failure with preserved ejection fraction through mitochondrial dysfunction and Akt S-nitrosylation.J Adv Res. 2023 Jan;43:175-186. doi: 10.1016/j.jare.2022.03.003. Epub 2022 Mar 5. J Adv Res. 2023. PMID: 36585107 Free PMC article.
-
Altered hepatic genes related to retinol metabolism and plasma retinol in patients with non-alcoholic fatty liver disease.PLoS One. 2018 Oct 31;13(10):e0205747. doi: 10.1371/journal.pone.0205747. eCollection 2018. PLoS One. 2018. PMID: 30379862 Free PMC article. Clinical Trial.
-
Focus on emerging drugs for the treatment of patients with non-alcoholic fatty liver disease.World J Gastroenterol. 2014 Dec 7;20(45):16841-57. doi: 10.3748/wjg.v20.i45.16841. World J Gastroenterol. 2014. PMID: 25492998 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical